3-hexaprenyl-4-hydroxybenzoic acid

Metabolite details

Identifier

LKMQQQABIGIHGL-LAAQXVIISA-N

InChI Key

LKMQQQABIGIHGL-LAAQXVIISA-N

IUPAC name

3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-4-hydroxybenzoic acid

Preferred name

3-hexaprenyl-4-hydroxybenzoic acid

INN name

—

Synonym

(all-E)-3-(3,7,11,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaenyl)-4-hydroxybenzoic acid

ChEBI

CHEBI:31116

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• LLIR_vs_Control
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT